Clinical and Translational Radiation Oncology (Jul 2020)

Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies

  • Amy J. Xu,
  • Leo Luo,
  • Jonathan E. Leeman,
  • Paul B. Romesser,
  • Daniel Spielsinger,
  • Christopher Sabol,
  • Todd Waldenberg,
  • Thomas Brinkman,
  • Nadeem Riaz,
  • Sean McBride,
  • Julie Kang,
  • Nancy Lee,
  • Chiaojung Jillian Tsai

Journal volume & issue
Vol. 23
pp. 30 – 34

Abstract

Read online

Purpose: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described. Methods and Materials: A single institution database was queried to retrospectively review treatment plans and select patients who underwent ≥ 3 courses of radiation to the head and neck region. Results: Thirty-three patients were found to have ≥ 3 courses of radiation with overlapping fields. Median local recurrence free survival after last course of reirradiation was 9.1 months and median overall survival was 10 months. Grade 3 and above toxicities were reported in 15 patients (45%). Grade 4 and above toxicities were reported in seven patients (21%). There was no grade 5 toxicity. 20 patients (61%) underwent subsequent therapies following completion of repeat reirradiation. Conclusions: Repeat reirradiation to the head and neck region is feasible and carries significant risks that are most appropriately managed with a multi-disciplinary team and must be balanced against the potential for local control and opportunities for emerging systemic therapies.

Keywords